311 related articles for article (PubMed ID: 29099951)
1. TumorFusions: an integrative resource for cancer-associated transcript fusions.
Hu X; Wang Q; Tang M; Barthel F; Amin S; Yoshihara K; Lang FM; Martinez-Ledesma E; Lee SH; Zheng S; Verhaak RGW
Nucleic Acids Res; 2018 Jan; 46(D1):D1144-D1149. PubMed ID: 29099951
[TBL] [Abstract][Full Text] [Related]
2. FusionGDB: fusion gene annotation DataBase.
Kim P; Zhou X
Nucleic Acids Res; 2019 Jan; 47(D1):D994-D1004. PubMed ID: 30407583
[TBL] [Abstract][Full Text] [Related]
3. The landscape and therapeutic relevance of cancer-associated transcript fusions.
Yoshihara K; Wang Q; Torres-Garcia W; Zheng S; Vegesna R; Kim H; Verhaak RG
Oncogene; 2015 Sep; 34(37):4845-54. PubMed ID: 25500544
[TBL] [Abstract][Full Text] [Related]
4. Unique genomic profile of fibrolamellar hepatocellular carcinoma.
Cornella H; Alsinet C; Sayols S; Zhang Z; Hao K; Cabellos L; Hoshida Y; Villanueva A; Thung S; Ward SC; Rodriguez-Carunchio L; Vila-Casadesús M; Imbeaud S; Lachenmayer A; Quaglia A; Nagorney DM; Minguez B; Carrilho F; Roberts LR; Waxman S; Mazzaferro V; Schwartz M; Esteller M; Heaton ND; Zucman-Rossi J; Llovet JM
Gastroenterology; 2015 Apr; 148(4):806-18.e10. PubMed ID: 25557953
[TBL] [Abstract][Full Text] [Related]
5. annoFuse: an R Package to annotate, prioritize, and interactively explore putative oncogenic RNA fusions.
Gaonkar KS; Marini F; Rathi KS; Jain P; Zhu Y; Chimicles NA; Brown MA; Naqvi AS; Zhang B; Storm PB; Maris JM; Raman P; Resnick AC; Strauch K; Taroni JN; Rokita JL
BMC Bioinformatics; 2020 Dec; 21(1):577. PubMed ID: 33317447
[TBL] [Abstract][Full Text] [Related]
6. Improved detection of clinically relevant fusion transcripts in cancer by machine learning classification.
Hafstað V; Häkkinen J; Larsson M; Staaf J; Vallon-Christersson J; Persson H
BMC Genomics; 2023 Dec; 24(1):783. PubMed ID: 38110872
[TBL] [Abstract][Full Text] [Related]
7. canEvolve: a web portal for integrative oncogenomics.
Samur MK; Yan Z; Wang X; Cao Q; Munshi NC; Li C; Shah PK
PLoS One; 2013; 8(2):e56228. PubMed ID: 23418540
[TBL] [Abstract][Full Text] [Related]
8. Novel transcription-induced fusion RNAs in prostate cancer.
Zhao S; Løvf M; Carm KT; Bakken AC; Hoff AM; Skotheim RI
Oncotarget; 2017 Jul; 8(30):49133-49143. PubMed ID: 28467780
[TBL] [Abstract][Full Text] [Related]
9. UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses.
Chandrashekar DS; Bashel B; Balasubramanya SAH; Creighton CJ; Ponce-Rodriguez I; Chakravarthi BVSK; Varambally S
Neoplasia; 2017 Aug; 19(8):649-658. PubMed ID: 28732212
[TBL] [Abstract][Full Text] [Related]
10. Genomic hotspots but few recurrent fusion genes in breast cancer.
Fimereli D; Fumagalli D; Brown D; Gacquer D; Rothé F; Salgado R; Larsimont D; Sotiriou C; Detours V
Genes Chromosomes Cancer; 2018 Jul; 57(7):331-338. PubMed ID: 29436103
[TBL] [Abstract][Full Text] [Related]
11. Oncofuse: a computational framework for the prediction of the oncogenic potential of gene fusions.
Shugay M; Ortiz de Mendíbil I; Vizmanos JL; Novo FJ
Bioinformatics; 2013 Oct; 29(20):2539-46. PubMed ID: 23956304
[TBL] [Abstract][Full Text] [Related]
12. Copy number alterations determined by single nucleotide polymorphism array testing in the clinical laboratory are indicative of gene fusions in pediatric cancer patients.
Busse TM; Roth JJ; Wilmoth D; Wainwright L; Tooke L; Biegel JA
Genes Chromosomes Cancer; 2017 Oct; 56(10):730-749. PubMed ID: 28597942
[TBL] [Abstract][Full Text] [Related]
13. Detecting and visualizing gene fusions.
Supper J; Gugenmus C; Wollnik J; Drueke T; Scherf M; Hahn A; Grote K; Bretschneider N; Klocke B; Zinser C; Cartharius K; Seifert M
Methods; 2013 Jan; 59(1):S24-8. PubMed ID: 23036331
[TBL] [Abstract][Full Text] [Related]
14. FuGePrior: A novel gene fusion prioritization algorithm based on accurate fusion structure analysis in cancer RNA-seq samples.
Paciello G; Ficarra E
BMC Bioinformatics; 2017 Jan; 18(1):58. PubMed ID: 28114882
[TBL] [Abstract][Full Text] [Related]
15. PCAT: an integrated portal for genomic and preclinical testing data of pediatric cancer patient-derived xenograft models.
Yang J; Li Q; Noureen N; Fang Y; Kurmasheva R; Houghton PJ; Wang X; Zheng S
Nucleic Acids Res; 2021 Jan; 49(D1):D1321-D1327. PubMed ID: 32810235
[TBL] [Abstract][Full Text] [Related]
16. Involvement of DPP9 in gene fusions in serous ovarian carcinoma.
Smebye ML; Agostini A; Johannessen B; Thorsen J; Davidson B; Tropé CG; Heim S; Skotheim RI; Micci F
BMC Cancer; 2017 Sep; 17(1):642. PubMed ID: 28893231
[TBL] [Abstract][Full Text] [Related]
17. A Multiplexed Amplicon Approach for Detecting Gene Fusions by Next-Generation Sequencing.
Beadling C; Wald AI; Warrick A; Neff TL; Zhong S; Nikiforov YE; Corless CL; Nikiforova MN
J Mol Diagn; 2016 Mar; 18(2):165-75. PubMed ID: 26747586
[TBL] [Abstract][Full Text] [Related]
18. Novel MYBL1 Gene Rearrangements with Recurrent MYBL1-NFIB Fusions in Salivary Adenoid Cystic Carcinomas Lacking t(6;9) Translocations.
Mitani Y; Liu B; Rao PH; Borra VJ; Zafereo M; Weber RS; Kies M; Lozano G; Futreal PA; Caulin C; El-Naggar AK
Clin Cancer Res; 2016 Feb; 22(3):725-33. PubMed ID: 26631609
[TBL] [Abstract][Full Text] [Related]
19. InFusion: Advancing Discovery of Fusion Genes and Chimeric Transcripts from Deep RNA-Sequencing Data.
Okonechnikov K; Imai-Matsushima A; Paul L; Seitz A; Meyer TF; Garcia-Alcalde F
PLoS One; 2016; 11(12):e0167417. PubMed ID: 27907167
[TBL] [Abstract][Full Text] [Related]
20. TumorNext: A comprehensive tumor profiling assay that incorporates high resolution copy number analysis and germline status to improve testing accuracy.
Gray PN; Vuong H; Tsai P; Lu HM; Mu W; Hsuan V; Hoo J; Shah S; Uyeda L; Fox S; Patel H; Janicek M; Brown S; Dobrea L; Wagman L; Plimack E; Mehra R; Golemis EA; Bilusic M; Zibelman M; Elliott A
Oncotarget; 2016 Oct; 7(42):68206-68228. PubMed ID: 27626691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
